13 studies were found.

1.		Completed	6-Hydroxymethylacylfulvene in Treating Patients With Stage IV Melanoma Condition: Stage IV Melanoma
2.		Recruiting	Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
3.		Completed	Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer Conditions: stage II prostate cancer; stage I prostate cancer
4.		No longer recruiting	Bryostatin 1 in Treating Patients With Stage IV Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer
5.		Completed	Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases Conditions: recurrent adult primary liver cancer; liver metastases; localized unresectable adult primary liver cancer
6.		No longer recruiting	Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors Conditions: adult anaplastic oligodendroglioma; adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas; recurrent adult brain tumor
7.		No longer recruiting	EMD 121974 in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
8.		Recruiting	Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
9.		Suspended	Gefitinib, Capecitabine, and Celecoxib in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
10.		No longer recruiting	Gene Therapy in Treating Patients With Metastatic Melanoma Conditions: Stage IV Melanoma; Recurrent Melanoma
11.		Recruiting	Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease Conditions: Non-small cell lung cancer; Small Cell Lung Cancer
12.		No longer recruiting	Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Conditions: recurrent grade I follicular small cleaved cell lymphoma; recurrent grade II follicular mixed cell lymphoma
13.		No longer recruiting	Isotretinoin With or Without Vitamin E for Prevention of Lung Cancer Conditions: Non-small cell lung cancer; Small Cell Lung Cancer; Drug Toxicity